chartexchange

PSNL
Personalis, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:00:20 PM EST
14.68USD-2.036%(-0.30)2,136,289
14.67Bid14.68Ask0.01Spread
Loading…
Loading…
Healthcare
Diagnostics & Research
HQ
Fremont, CA, USA
Previous Close
$14.98
Beta
2.21
52-Week High
$18.89 2026-08-21
52-Week Low
$4.96 2026-04-29
SMA 50
$15.96
SMA 200
$11.66
Avg. Vol 10D
2.76M
Avg. Vol 30D
2.42M
Avg. Vol 90D
3.10M
Relative Vol
0.88
108.40M
73.02M
0.4100%
3,800,000
14,200
PSNL Profile

personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.

PSNL Performance
PeriodPriceDateChangeBeta
1W15.862026-11-12-7.41%3.625
1M15.882026-10-19-7.53%0.580
3M15.812026-08-19-7.12%0.443
6M7.042026-05-19+108.59%1.472
1Y8.242025-11-19+78.22%2.206
2Y3.692024-11-19+297.97%—
5Y14.952021-11-19-1.77%2.204
PSNL Stock Summary

Personalis, Inc. Common Stock (NASDAQ:PSNL) stock price today is $14.69, and today's volume is 2,132,263. PSNL is down 1.969% today. The 30 day average volume is 2.42M. PSNL market cap is $1.59B with 108.40M shares outstanding.